Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

NCT05413850 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
mCRPC
Urogenital Neoplasms
Prostatic Neoplasms
Prostatic Diseases

Interventions

DRUG: Lutetium (177Lu) rhPSMA-10.1 Injection
DIAGNOSTIC_TEST: 18F-rhPSMA-7.3 injection (in phase 1 only)

Sponsor

Blue Earth Therapeutics Ltd

Collaborators

[object Object]